HIGHLIGHTS
- who: Linlin Zhang et al. from the Department of Medical Oncology, Tianjin Medical University General Hospital, Tianjin, China have published the article: STRN-ALK Fusion in Lung Adenocarcinoma with Brain Metastasis Responded Well to Ensartinib: A Case Report, in the Journal: (JOURNAL) of 21/09/2022
- what: The aim of this report is to provide more evidence for therapeutic strategy selecting for the treatment of NSCLC patient due to STRN-ALK fusion.
SUMMARY
EML4-ALK fusion is the most common ALK rearrangement detected in non-small cell lung cancer (NSCLC) patients . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.